跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 世銘
教授
,
臨床藥學學科
https://orcid.org/0000-0002-0273-4847
電子郵件
smchen
tmu.edu
tw
h-index
802
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2002
2025
每年研究成果
概覽
指紋
網路
專案
(9)
研究成果
(48)
資料集
(1)
類似的個人檔案
(6)
指紋
查看啟用 Shih-Ming Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
2,5-Dimethoxy-4-iodoamphetamine
10%
3 Hydroxybutyric Acid
10%
4 Aminohippuric Acid
10%
6 N Carboxymethyllysine
10%
Anti-Inflammatory Drug
12%
Aristolochic Acid
100%
Atorvastatin
10%
Beers Criteria
10%
Biological Marker
18%
Bupleurum
10%
C3H/He Mouse
12%
Chitosan
43%
Cohort Study
34%
Creatinine
23%
Diabetes Mellitus
36%
Disorders of Mitochondrial Functions
10%
End Stage Renal Disease
12%
Gentamicin
33%
Ginsenoside Rg 1
10%
Glyoxalase
10%
Heparin
10%
High Performance Liquid Chromatography
28%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
15%
Inbred Mouse Strain
23%
Inducible Nitric Oxide Synthase
10%
Kidney Disease
70%
Kidney Injury
29%
Lactic Acid
75%
Lipoprotein Lipase
10%
Metformin
55%
Methylglyoxal
70%
Microalbuminuria
14%
Mouse
81%
Mouse Model
12%
Negative Syndrome
16%
Nephritis
43%
Nephrotoxicity
89%
Nitric Oxide
10%
Non Insulin Dependent Diabetes Mellitus
12%
Pancreatic Lipase
10%
Pharmacokinetics
21%
Positive Syndrome
16%
Prednisolone
10%
Random Effects Model
13%
Randomized Controlled Trial
13%
Saikosaponin
10%
Saikosaponin C
10%
Saponin
12%
Statin (Protein)
27%
Streptozotocin
21%
Medicine and Dentistry
4 Iodo 2,5 Dimethoxyamphetamine
10%
Antipsychotic
10%
Aristolochic Acid
21%
C57BL/6
7%
Chinese Herbal Medicine
10%
Chitosan
10%
Cohort Analysis
32%
Colchicine
10%
Diabetes Mellitus
23%
Diagnosis
11%
Disorders of Mitochondrial Functions
10%
Drug Therapy
10%
End Stage Renal Disease
10%
Gentamicin
10%
Ginseng Extract
6%
Ginsenoside Rg 1
10%
Glomerulus Basement Membrane
7%
Glycon
43%
Group Therapy
5%
Hazard Ratio
6%
Incretin
10%
Interstitial Nephritis
7%
Kampo
10%
Kidney Function
12%
Lactic Acid
10%
Maturity Onset Diabetes of the Young
12%
Meta-Analysis
21%
Methylglyoxal
10%
Nephritic Syndrome
21%
Nephropathy
8%
Nephrotoxicity
21%
Optimal Drug Dose
10%
Patient with Type 2 Diabetes
10%
Saikosaponin C
10%
Systematic Review
21%
Tuberculosis
7%
Urinary System
5%
